Bouker KB - Search Results

1

The A4396G polymorphism in interferon regulatory factor 1 is frequently expressed in breast cancer cell lines.

Bouker KB, Skaar TC, Harburger DS, Riggins RB, Fernandez DR, Zwart A, Clarke R. Bouker KB, et al. Cancer Genet Cytogenet. 2007 May;175(1):61-4. doi: 10.1016/j.cancergencyto.2006.12.008. Cancer Genet Cytogenet. 2007. PMID: 17498560

2

Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780).

Gu Z, Lee RY, Skaar TC, Bouker KB, Welch JN, Lu J, Liu A, Zhu Y, Davis N, Leonessa F, Brünner N, Wang Y, Clarke R. Gu Z, et al. Among authors: bouker kb. Cancer Res. 2002 Jun 15;62(12):3428-37. Cancer Res. 2002. PMID: 12067985

3

interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (faslodex, fulvestrant).

Bouker KB, Skaar TC, Fernandez DR, O'Brien KA, Riggins RB, Cao D, Clarke R. Bouker KB, et al. Cancer Res. 2004 Jun 1;64(11):4030-9. doi: 10.1158/0008-5472.CAN-03-3602. Cancer Res. 2004. PMID: 15173018

4

Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis.

Bouker KB, Skaar TC, Riggins RB, Harburger DS, Fernandez DR, Zwart A, Wang A, Clarke R. Bouker KB, et al. Carcinogenesis. 2005 Sep;26(9):1527-35. doi: 10.1093/carcin/bgi113. Epub 2005 May 5. Carcinogenesis. 2005. PMID: 15878912

5

Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling.

Clarke R, Liu MC, Bouker KB, Gu Z, Lee RY, Zhu Y, Skaar TC, Gomez B, O'Brien K, Wang Y, Hilakivi-Clarke LA. Clarke R, et al. Among authors: bouker kb. Oncogene. 2003 Oct 20;22(47):7316-39. doi: 10.1038/sj.onc.1206937. Oncogene. 2003. PMID: 14576841 Review.

6

Effects of In Utero Exposure to Ethinyl Estradiol on Tamoxifen Resistance and Breast Cancer Recurrence in a Preclinical Model.

Hilakivi-Clarke L, Wärri A, Bouker KB, Zhang X, Cook KL, Jin L, Zwart A, Nguyen N, Hu R, Cruz MI, de Assis S, Wang X, Xuan J, Wang Y, Wehrenberg B, Clarke R. Hilakivi-Clarke L, et al. Among authors: bouker kb. J Natl Cancer Inst. 2016 Sep 8;109(1):djw188. doi: 10.1093/jnci/djw188. Print 2017 Jan. J Natl Cancer Inst. 2016. PMID: 27609189 Free PMC article.

7

Molecular and pharmacological aspects of antiestrogen resistance.

Clarke R, Skaar TC, Bouker KB, Davis N, Lee YR, Welch JN, Leonessa F. Clarke R, et al. Among authors: bouker kb. J Steroid Biochem Mol Biol. 2001 Jan-Mar;76(1-5):71-84. doi: 10.1016/s0960-0760(00)00193-x. J Steroid Biochem Mol Biol. 2001. PMID: 11384865 Review.

8

Do estrogens always increase breast cancer risk?

Hilakivi-Clarke L, Cabanes A, Olivo S, Kerr L, Bouker KB, Clarke R. Hilakivi-Clarke L, et al. Among authors: bouker kb. J Steroid Biochem Mol Biol. 2002 Feb;80(2):163-74. doi: 10.1016/s0960-0760(01)00184-4. J Steroid Biochem Mol Biol. 2002. PMID: 11897501 Review.

9

Antiestrogen Resistance and the Application of Systems Biology.

Bouker KB, Wang Y, Xuan J, Clarke R. Bouker KB, et al. Drug Discov Today Dis Mech. 2012;9(1-2):e11-e17. doi: 10.1016/j.ddmec.2012.10.003. Epub 2012 Dec 1. Drug Discov Today Dis Mech. 2012. PMID: 23539064 Free PMC article.

10

Inhibition of Antiestrogen-Promoted Pro-Survival Autophagy and Tamoxifen Resistance in Breast Cancer through Vitamin D Receptor.

Li Y, Cook KL, Yu W, Jin L, Bouker KB, Clarke R, Hilakivi-Clarke L. Li Y, et al. Among authors: bouker kb. Nutrients. 2021 May 19;13(5):1715. doi: 10.3390/nu13051715. Nutrients. 2021. PMID: 34069442 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters